Form EFFECT AGILE THERAPEUTICS INC
- S&P 500, Nasdaq close up 4th straight week as optimism grows
- 'Back in Tech': Investors are Increasing Exposure to Tech and Growth Stocks - BofA
- Rivian Reports Bigger Loss, Says Current Models Won't Qualify for Tax Breaks
- US-listed China Stocks Slip on Delisting Moves, Analyst Sees Short-term Noise
- Salesforce (CRM), Snowflake (SNOW) Rated New Sell at Guggenheim, Oracle (ORCL) at Buy
Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.
|SECURITIES AND EXCHANGE COMMISSION|
|Washington, D.C. 20549|
|Notice of Effectiveness|
|Effectiveness Date:||July 1, 2022 9:00 A.M.|
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Agile Therapeutics Reports Second Quarter 2022 Financial Results and Provides Corporate Update
- First Street Foundation Finds an emerging "Extreme Heat Belt" will Impact Over 107 Million Americans by 2053
- CGTN poll: 78.34% of people believe China vitalized world economy
Create E-mail Alert Related CategoriesSEC Filings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!